The Effect of BDNF Gene on Bipolar Disorder
DOI:
https://doi.org/10.62051/czwjhj14Keywords:
BDNF gene; bipolar disorder; Neuroregeneration.Abstract
BDNF (brain-derived neurotrophic factor) is a kind of neurotrophic protein, widely distributed in the brain and spinal cord. BDNF is engaged in regulating the growth and migration of neurons, and can promote the repair of damaged neurons. While disorders of BDNF expression can lead to mental diseases such as bipolar disorder. The main way in which the BDNF gene affects bipolar disorder is through BDNF's interaction with TrkB receptors. In addition, BDNF also causes bipolar disorder by affecting the amygdala and hippocampus, promoting neuronal regeneration, and participating in synaptic plasticity. At present, there are still some questions in the field of bipolar disorder and BDNF gene research. The pathological mechanism of bipolar disorder is still unclear, and the clinical application of BDNF has many difficulties. This article reviews the BDNF gene influences the role and mechanism of bipolar disorder and the evidence that BDNF gene causes bipolar disorder, hoping to provide a new direction for the treatment of bipolar disorder.
Downloads
References
A.S. Clemente et al. bipolar disorder prevalence: A systematic review and meta-analysis of the literature, Revista Brasileira de Psiquiatria, 2015, 37 (2), pp. 155 – 161.
H. Park et al. Neurotrophin regulation of neural circuit development and function. Nature reviews. Neuroscience, 2013, 14 (1), pp. 7 – 23.
C. Björkholm et al. BDNF – a key transducer of antidepressant effects. Neuropharmacology, 2016, 102, pp. 72 – 79.
H. Yu et al. Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants. The Journal of neuroscience: the official journal of the Society for Neuroscience, 2012, 32 (12), pp. 4092 – 4101.
B. Hing et al. A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity. Biological psychiatry, 2012, 71 (7), pp. 618 – 626.
C. B. Hartberg et al. Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder. Bipolar disorders, 2015, 17 (5), pp. 496 – 506.
M. M. Perez-Rodriguez et.al. Brain-derived neurotrophic factor Val66Met genotype modulates amygdala habituation. Psychiatry Res. Neuroimaging.2017, 263, pp. 85 – 92.
D Janiri et al. Amygdala and hippocampus volumes are differently affected by childhood trauma in patients with bipolar disorders and healthy controls. Bipolar Disorders 2017, pp. 353 – 362.
M. Aas et al. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Progress in neuro-psychopharmacology & biological psychiatry, 2013, 46, pp. 181 – 188.
M. B. Lachyankar et a1. Embryonic precursor cells that express Trk receptors: induction ofdifferentcellfatesbyNGF, BDNF, NT3, and CNTF, ExpNeurol, 1997, pp. 350 – 360.
W. J. Tyler et.al. Miniature synaptic transmission and BDNF modulate dendritic spine growth and form in rat CA1 neurones. J. Physiol. 2003, 553 pp. 497 – 509.
H. Qiao et al. Role of pro-BDNF and BDNF in dendritic spine plasticity and depressive-like behaviors induced by an animal model of depression. Brain Res, 2017, 1663, pp. 29 – 37.
C. López-Jaramillo et al. Increased hippocampal, thalamus and amygdala volume in long-term lithium-treated bipolar I disorder patients compared with unmedicated patients and healthy subjects. Bipolar Disorders, 2017, 19 (1), pp. 41 – 49.
S. Yasuda et al. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry. 2009, 14 (1), pp. 51 - 59.
K. E. Savell et al. A Neuron-Optimized CRISPR/dCas9 Activation System for Robust and Specific Gene Regulation. eNeuro, 2019, 6 (1).
W. Jin. Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease. Journal of clinical medicine, 2020, 9 (1), pp. 257.
Downloads
Published
Conference Proceedings Volume
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
